ADIPOQ and polycystic ovary syndrome: A meta-analysis of 10 randomized clinical trials showed that n-3 PUFA supplementation decreased serum hs-CRP and increased serum adiponectin levels [90], confirming the benefit of n-3 PUFAs in reducing systemic inflammation in women with PCOS.